AAAAAA

   
Results: 1-25 | 26-50 | 51-61
Results: 1-25/61
A RANDOMIZED PHASE-II STUDY OF ORAL PAMIDRONATE FOR THE TREATMENT OF BONE METASTASES FROM BREAST-CANCER
Authors: COLEMAN RE HOUSTON S PUROHIT OP RUBENS RD KANDRA A FORD J
Citation: Re. Coleman et al., A RANDOMIZED PHASE-II STUDY OF ORAL PAMIDRONATE FOR THE TREATMENT OF BONE METASTASES FROM BREAST-CANCER, European journal of cancer, 34(6), 1998, pp. 820-824
LOCALLY ADVANCED AND METASTATIC BREAST-CANCER
Authors: RUBENS RD
Citation: Rd. Rubens, LOCALLY ADVANCED AND METASTATIC BREAST-CANCER, European journal of cancer, 34, 1998, pp. 31-31
BONE METASTASES - THE CLINICAL PROBLEM
Authors: RUBENS RD
Citation: Rd. Rubens, BONE METASTASES - THE CLINICAL PROBLEM, European journal of cancer, 34(2), 1998, pp. 210-213
THE TOLERABILITY AND ADVERSE EVENT PROFILE OF PAMIDRONATE DISODIUM
Authors: HOUSTON SJ RUBENS RD
Citation: Sj. Houston et Rd. Rubens, THE TOLERABILITY AND ADVERSE EVENT PROFILE OF PAMIDRONATE DISODIUM, Reviews in contemporary pharmacotherapy, 9(3), 1998, pp. 213-224
DOXORUBICIN PHARMACOKINETICS - THE EFFECT OF ABNORMAL LIVER BIOCHEMISTRY TESTS
Authors: TWELVES CJ DOBBS NA GILLIES HC JAMES CA RUBENS RD HARPER PG
Citation: Cj. Twelves et al., DOXORUBICIN PHARMACOKINETICS - THE EFFECT OF ABNORMAL LIVER BIOCHEMISTRY TESTS, Cancer chemotherapy and pharmacology, 42(3), 1998, pp. 229-234
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
DO PATIENTS WITH ADVANCED BREAST-CANCER BENEFIT FROM CHEMOTHERAPY
Authors: RAMIREZ AJ TOWLSON KE LEANING MS RICHARDS MA RUBENS RD
Citation: Aj. Ramirez et al., DO PATIENTS WITH ADVANCED BREAST-CANCER BENEFIT FROM CHEMOTHERAPY, British Journal of Cancer, 78(11), 1998, pp. 1488-1494
UNTITLED - REPLY TO THE LETTER FROM ROBERTSON TO BLAMEY
Authors: COLEMAN RE RUBENS RD
Citation: Re. Coleman et Rd. Rubens, UNTITLED - REPLY TO THE LETTER FROM ROBERTSON TO BLAMEY, British Journal of Cancer, 78(10), 1998, pp. 1397-1397
PROGNOSTIC-SIGNIFICANCE OF STROMELYSIN-3 (ST3) LEVELS IN HUMAN BREAST-CANCER AND DEMONSTRATION OF NOVEL ST3 EXPRESSION LN METAPLASTIC BREAST-CARCINOMA CELLS WHICH HAVE UNDERGONE EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT)
Authors: AHMAD A HANBY A DUBLIN EA RUBENS RD BARNES DM HART IR
Citation: A. Ahmad et al., PROGNOSTIC-SIGNIFICANCE OF STROMELYSIN-3 (ST3) LEVELS IN HUMAN BREAST-CANCER AND DEMONSTRATION OF NOVEL ST3 EXPRESSION LN METAPLASTIC BREAST-CARCINOMA CELLS WHICH HAVE UNDERGONE EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT), British Journal of Cancer, 78, 1998, pp. 77-77
CLINICAL COURSE AND PROGNOSTIC FACTORS FOLLOWING BONE RECURRENCE FROMBREAST-CANCER
Authors: COLEMAN RE SMITH P RUBENS RD
Citation: Re. Coleman et al., CLINICAL COURSE AND PROGNOSTIC FACTORS FOLLOWING BONE RECURRENCE FROMBREAST-CANCER, British Journal of Cancer, 77(2), 1998, pp. 336-340
FAMILY HISTORY AND SURVIVAL IN PREMENOPAUSAL BREAST-CANCER
Authors: MOHAMMED SN SMITH P HODGSON SV FENTIMAN IS MILES DW BARNES DM MILLIS RR RUBENS RD
Citation: Sn. Mohammed et al., FAMILY HISTORY AND SURVIVAL IN PREMENOPAUSAL BREAST-CANCER, British Journal of Cancer, 77(12), 1998, pp. 2252-2256
LARGE OPERABLE BREAST-CANCER - THE APPLICABILITY OF PRIMARY CHEMOTHERAPY
Authors: RUBENS RD RICHARDS MA RAMIREZ AJ COYNE GB CHAUDARY MA FENTIMAN IS TONG D WINTER PJ
Citation: Rd. Rubens et al., LARGE OPERABLE BREAST-CANCER - THE APPLICABILITY OF PRIMARY CHEMOTHERAPY, Breast, 6(1), 1997, pp. 45-50
AROMATASE INHIBITORS FOR BREAST-CANCER - FURTHER PROGRESS
Authors: RUBENS RD
Citation: Rd. Rubens, AROMATASE INHIBITORS FOR BREAST-CANCER - FURTHER PROGRESS, European journal of cancer, 33(7), 1997, pp. 989-990
THE ROLE OF DOCETAXEL IN IMPROVING TREATMENT OUTCOMES IN ADVANCED BREAST-CANCER
Authors: RUBENS RD
Citation: Rd. Rubens, THE ROLE OF DOCETAXEL IN IMPROVING TREATMENT OUTCOMES IN ADVANCED BREAST-CANCER, European journal of cancer, 33, 1997, pp. 1-2
LOCO-REGIONAL RECURRENCE FOLLOWING MASTECTOMY FOR EARLY BREAST-CARCINOMA - EFFICACY OF RADIOTHERAPY AT THE TIME OF RECURRENCE
Authors: CHAUDARY MA TONG D MILLIS R SMITH P FENTIMAN IS RUBENS RD
Citation: Ma. Chaudary et al., LOCO-REGIONAL RECURRENCE FOLLOWING MASTECTOMY FOR EARLY BREAST-CARCINOMA - EFFICACY OF RADIOTHERAPY AT THE TIME OF RECURRENCE, European journal of surgical oncology, 23(4), 1997, pp. 348-353
HORMONAL-THERAPY PROLONGS SURVIVAL IN IRRADIATED LOCALLY ADVANCED BREAST-CANCER - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER RANDOMIZED PHASE-III TRIAL
Authors: BARTELINK H RUBENS RD VANDERSCHUEREN E SYLVESTER R
Citation: H. Bartelink et al., HORMONAL-THERAPY PROLONGS SURVIVAL IN IRRADIATED LOCALLY ADVANCED BREAST-CANCER - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER RANDOMIZED PHASE-III TRIAL, Journal of clinical oncology, 15(1), 1997, pp. 207-215
RELATIONSHIP BETWEEN P53 STAINING AND THE EFFECT OF ADJUVANT CHEMOTHERAPY IN PATIENTS WITH PRIMARY NODE-POSITIVE BREAST-CANCER
Authors: DUBLIN EA RUBENS RD MILES DW SMITH P BARNES DM
Citation: Ea. Dublin et al., RELATIONSHIP BETWEEN P53 STAINING AND THE EFFECT OF ADJUVANT CHEMOTHERAPY IN PATIENTS WITH PRIMARY NODE-POSITIVE BREAST-CANCER, Journal of pathology, 181, 1997, pp. 23-23
P53 IMMUNOHISTOCHEMICAL STAINING AND SURVIVAL AFTER ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
Authors: DUBLIN EA MILES DW RUBENS RD SMITH P BARNES DM
Citation: Ea. Dublin et al., P53 IMMUNOHISTOCHEMICAL STAINING AND SURVIVAL AFTER ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER, International journal of cancer, 74(6), 1997, pp. 605-608
KEY ISSUES IN THE TREATMENT OF ADVANCED BREAST-CANCER - EXPECTATIONS AND OUTCOMES
Authors: RUBENS RD
Citation: Rd. Rubens, KEY ISSUES IN THE TREATMENT OF ADVANCED BREAST-CANCER - EXPECTATIONS AND OUTCOMES, PharmacoEconomics, 9, 1996, pp. 1-7
BREAST-CANCER
Authors: BLICHERTTOFT M RUBENS RD
Citation: M. Blicherttoft et Rd. Rubens, BREAST-CANCER, The European journal of surgery, 162(2), 1996, pp. 83-85
ENHANCING THE EFFECT OF THERATOPE STN-KLH CANCER VACCINE IN PATIENTS WITH METASTATIC BREAST-CANCER BY PRETREATMENT WITH LOW-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE
Authors: MACLEAN GD MILES DW RUBENS RD REDDISH MA LONGENECKER BM
Citation: Gd. Maclean et al., ENHANCING THE EFFECT OF THERATOPE STN-KLH CANCER VACCINE IN PATIENTS WITH METASTATIC BREAST-CANCER BY PRETREATMENT WITH LOW-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 309-316
MANAGEMENT OF CHEMOTHERAPY-RESISTANT BREAST-CANCER
Authors: MILES DW RUBENS RD
Citation: Dw. Miles et Rd. Rubens, MANAGEMENT OF CHEMOTHERAPY-RESISTANT BREAST-CANCER, Breast, 5(4), 1996, pp. 288-292
INADEQUACY OF IRIDIUM IMPLANT AS SOLE RADIATION TREATMENT FOR OPERABLE BREAST-CANCER
Authors: FENTIMAN IS POOLE C TONG D WINTER PJ GREGORY WM MAYLES HMO TURNER P CHAUDARY MA RUBENS RD
Citation: Is. Fentiman et al., INADEQUACY OF IRIDIUM IMPLANT AS SOLE RADIATION TREATMENT FOR OPERABLE BREAST-CANCER, European journal of cancer, 32A(4), 1996, pp. 608-611
CHARACTERIZATION OF COMPLETE RESPONDERS TO COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A RETROSPECTIVE EORTC BREAST GROUP-STUDY
Authors: TOMIAK E PICCART M MIGNOLET F SAHMOUD T PARIDAENS R NOOY M BEEX L FENTIMAN IS MULLER A VANDERSCHUEREN E RUBENS RD
Citation: E. Tomiak et al., CHARACTERIZATION OF COMPLETE RESPONDERS TO COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A RETROSPECTIVE EORTC BREAST GROUP-STUDY, European journal of cancer, 32A(11), 1996, pp. 1876-1887
ADHESION MOLECULE EXPRESSION AND LEUKOCYTE TRAFFICKING FOLLOWING IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2
Authors: MILES DW HAPPERFIELD LC BOBROW LG RUBENS RD
Citation: Dw. Miles et al., ADHESION MOLECULE EXPRESSION AND LEUKOCYTE TRAFFICKING FOLLOWING IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2, Histopathology, 28(4), 1996, pp. 301-308
Risultati: 1-25 | 26-50 | 51-61